Director Steven Hoerter gets 62,000 C4 Therapeutics (CCCC) options at $4.25
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
C4 Therapeutics, Inc. director Steven L. Hoerter received a grant of stock options covering 62,000 shares of Common Stock. The options have an exercise price of $4.25 per share and expire on June 23, 2036.
According to the footnote, the entire option vests and becomes exercisable on the earlier of June 24, 2027 or the company’s next annual stockholder meeting, assuming he continues to serve on the Board through that date. After this grant, he holds 62,000 options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hoerter Steven L.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 62,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 62,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 62,000 options
Exercise price: $4.25 per share
Expiration date: June 23, 2036
+2 more
5 metrics
Options granted
62,000 options
Stock Option (Right to Buy) grant to director on June 24, 2026
Exercise price
$4.25 per share
Exercise price for the 62,000 stock options
Expiration date
June 23, 2036
Option expiration for the granted stock options
Underlying shares
62,000 shares
Common Stock underlying the granted options
Holdings after grant
62,000 options
Total derivative holdings following this transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, Common Stock, +2 more
6 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 4.2500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-23T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
vest and become exercisable financial
"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027..."
FAQ
What did C4 Therapeutics (CCCC) report in this Form 4 for Steven L. Hoerter?
C4 Therapeutics reported a stock option grant to director Steven L. Hoerter. He received options for 62,000 shares of Common Stock as a compensation award, recorded as an acquisition rather than an open-market purchase, with specific vesting and expiration terms.
What is the exercise price on Steven Hoerter’s C4 Therapeutics (CCCC) stock options?
The exercise price on the options is $4.25 per share. This means that, once vested, he can purchase C4 Therapeutics Common Stock at $4.25 per share until the options reach their stated expiration date.
When do Steven Hoerter’s C4 Therapeutics (CCCC) options vest and become exercisable?
The options vest in full on the earlier of June 24, 2027 or the next annual stockholder meeting. Vesting is conditional on his continued service as a member of the Board through that date, according to the disclosed footnote.
When do Steven Hoerter’s C4 Therapeutics (CCCC) stock options expire?
The stock options expire on June 23, 2036. After that expiration date, he can no longer exercise the options to purchase Common Stock, even if they were previously vested and exercisable under the grant’s terms.